• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 6900PTFX
Medical Device Problem Codes Device Dislodged or Dislocated (2923); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Pulmonary Hypertension (4460); Insufficient Information (4580)
Date of Event 02/29/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event or Problem Description
It was learned through implant patient registry that a 6900ptfx 29mm valve, implanted in mitral position, was explanted after an implant duration of 3 years and 11 months due to unknown reasons.The valve was replaced with a 11400m 29mm valve.
 
Additional Manufacturer Narrative
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Device dehiscence or suture torn out may occur early or late.When it occurs in the intraoperative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Valve dehiscence is not a malfunction related to a manufacturing deficiency of the device.An engineering evaluation is not required because there is no allegation of a malfunction which could be related to a manufacturing non-conformance and/or one was not suspected or confirmed through investigation; no labeling non-conformance/deficiency; no use-related issue with a hazardous situation; no device-related infection; and no evidence of a product failure with regard to design, reliability, or use error.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regard to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.A capa/scar/pra is not required as there are no confirmed product or labeling non-conformances and no other triggers are met.A definitive root cause cannot be conclusively determined; however, patient factors likely caused or contributed.
 
Event or Problem Description
It was learned through implant patient registry and investigation that a 6900ptfx 29mm valve, implanted in mitral position, was explanted after an implant duration of 3 years and 11 months due to suture dehiscence and perivalvular leak.The valve was replaced with a 11400m 29mm valve.Per medical records the patient presented with pulmonary htn and underwent avr with 23mm inspiris valve and redo-mvr.Intraoperatively the mitral valve was exposed, there was an area of dehiscence between the superior trigone and posterior annulus approximately 2cm.The stiches appear to be pulled through the annulus.All the sutures holding the valve were removed, there was no vegetations seen.The posterior leaflet structures were kept intact.The annulus was sized to a 29mm mitris valve and was secured with interrupted pledget sutures, the stiches at the trigone were aligned with the valve.Post procedure tee showed good function of the aortic and mitral valves.The patient was transported to icu in critical condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS
Common Device Name
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 90262
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
irvine, CA 92614
9492500222
MDR Report Key19638017
Report Number2015691-2024-04977
Device Sequence Number15594331
Product Code DYE
UDI-Device Identifier00690103163605
UDI-Public(01)00690103163605(17)220324
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P860057
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/24/2022
Device Model Number6900PTFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/04/2024
Supplement Date Received by Manufacturer07/23/2024
Initial Report FDA Received Date06/28/2024
Supplement Report FDA Received Date08/13/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/25/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Hospitalization; Required Intervention;
Patient Age69 YR
Patient SexMale
-
-